PKLR
Pyruvate kinase PKLR
Also known as: KPYR_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30613
- Gene
- PKLR
- Ensembl
- ENSG00000143627
- Chromosome
- 1
- Canonical length
- 574 aa
- Protein class
- Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a pyruvate kinase that catalyzes the transphosphorylation of phohsphoenolpyruvate into pyruvate and ATP, which is the rate-limiting step of glycolysis. Defects in this enzyme, due to gene mutations or genetic variations, are the common cause of chronic hereditary nonspherocytic hemolytic anemia (CNSHA or HNSHA). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
574 residues, UniProt reviewed canonical sequence.
>P30613|PKLR
1 MSIQENISSL QLRSWVSKSQ RDLAKSILIG APGGPAGYLR RASVAQLTQE LGTAFFQQQQ
61 LPAAMADTFL EHLCLLDIDS EPVAARSTSI IATIGPASRS VERLKEMIKA GMNIARLNFS
121 HGSHEYHAES IANVREAVES FAGSPLSYRP VAIALDTKGP EIRTGILQGG PESEVELVKG
181 SQVLVTVDPA FRTRGNANTV WVDYPNIVRV VPVGGRIYID DGLISLVVQK IGPEGLVTQV
241 ENGGVLGSRK GVNLPGAQVD LPGLSEQDVR DLRFGVEHGV DIVFASFVRK ASDVAAVRAA
301 LGPEGHGIKI ISKIENHEGV KRFDEILEVS DGIMVARGDL GIEIPAEKVF LAQKMMIGRC
361 NLAGKPVVCA TQMLESMITK PRPTRAETSD VANAVLDGAD CIMLSGETAK GNFPVEAVKM
421 QHAIAREAEA AVYHRQLFEE LRRAAPLSRD PTEVTAIGAV EAAFKCCAAA IIVLTTTGRS
481 AQLLSRYRPR AAVIAVTRSA QAARQVHLCR GVFPLLYREP PEAIWADDVD RRVQFGIESG
541 KLRGFLRVGD LVIVVTGWRP GSGYTNIMRV LSISLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PKLR can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 87 nTPM
Expression across tissuesHPA
Tissue
- liver: 87 nTPM
- kidney: 24 nTPM
- bone marrow: 18 nTPM
- duodenum: 11 nTPM
- small intestine: 6.8 nTPM
- cerebellum: 1.5 nTPM
Single-cell type
- proximal tubule cells: 11 nCPM
- erythrocyte progenitors: 8.9 nCPM
- late spermatids: 7 nCPM
- early spermatids: 1.6 nCPM
- erythrocytes: 1.5 nCPM
- other brain neurons: 1.4 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebellum: 1.7 nTPM
- hypothalamus: 1.3 nTPM
- pons: 0.9 nTPM
- midbrain: 0.7 nTPM
- medulla oblongata: 0.6 nTPM
- basal ganglia: 0.5 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PKLR.
Disease | AllUniProt
Conditions PKLR is implicated in, by any mechanism.
- Pyruvate kinase hyperactivity (PKHYP) MIM:102900
- Anemia, congenital, non-spherocytic hemolytic, 2 (CNSHA2) MIM:266200
Disease | GeneticClinVar
115 pathogenic / likely-pathogenic of 461 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Pyruvate kinase deficiency of red cells
- PKLR-related disorder
- Pyruvate kinase hyperactivity
- Congenital anemia
- Inborn genetic diseases
Disease | ImmuneIEDB
Conditions an epitope on PKLR was assayed in.
- multiple sclerosis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- -0.2
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to epinephrine stimulus
- cellular response to insulin stimulus
- glycolytic process
- pyruvate biosynthetic process
- response to ATP
- response to cAMP
- response to glucose
- response to hypoxia
- response to metal ion
- response to nutrient
Molecular functions
- ATP binding
- kinase activity
- magnesium ion binding
- monosaccharide binding
- potassium ion binding
- pyruvate kinase activity
Cellular components
- cytoplasm
- cytosol
- extracellular exosome
- pyruvate kinase complex
Protein domainsUniProt · Pfam · InterPro
- Pyruvate kinase
- Pyruvate kinase-like, insert domain superfamily
- Pyruvate kinase, barrel
- Pyruvate kinase, C-terminal
- Pyruvate kinase, insert domain superfamily
- Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily
- Pyruvate kinase, active site
- Pyruvate kinase, C-terminal domain superfamily
- Pyruvate kinase-like domain superfamily
- Pyruvate kinase, barrel domain
- Pyruvate kinase, alpha/beta domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PKLR as an antibody target. Whether an autoantibody or antibody against PKLR could matter depends on whether native PKLR is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PKLR is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PKLR as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...